• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KIR 和 NK 细胞重建对造血干细胞移植结局的影响。

Influence of KIR and NK Cell Reconstitution in the Outcomes of Hematopoietic Stem Cell Transplantation.

机构信息

Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

Institute of Hematology, Zhejiang University, Hangzhou, China.

出版信息

Front Immunol. 2020 Sep 2;11:2022. doi: 10.3389/fimmu.2020.02022. eCollection 2020.

DOI:10.3389/fimmu.2020.02022
PMID:32983145
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7493622/
Abstract

Natural killer (NK) cells play a significant role in immune tolerance and immune surveillance. Killer immunoglobin-like receptors (KIRs), which recognize human leukocyte antigen (HLA) class I molecules, are particularly important for NK cell functions. Previous studies have suggested that, in the setting of hematopoietic stem cell transplantation (HSCT), alloreactive NK cells from the donor could efficiently eliminate recipient tumor cells and the residual immune cells. Subsequently, several clinical models were established to determine the optimal donors who would exhibit a graft-vs. -leukemia (GVL) effect without developing graft-vs. -host disease (GVHD). In addition, hypotheses about specific beneficial receptor-ligand pairs and KIR genes have been raised and the favorable effects of alloreactive NK cells are being investigated. Moreover, with a deeper understanding of the process of NK cell reconstitution post-HSCT, new factors involved in this process and the defects of previous models have been observed. In this review, we summarize the most relevant literatures about the impact of NK cell alloreactivity on transplant outcomes and the factors affecting NK cell reconstitution.

摘要

自然杀伤 (NK) 细胞在免疫耐受和免疫监视中发挥重要作用。识别人类白细胞抗原 (HLA) Ⅰ类分子的杀伤免疫球蛋白样受体 (KIR) 对 NK 细胞功能尤为重要。先前的研究表明,在造血干细胞移植 (HSCT) 中,供体的同种反应性 NK 细胞可以有效地消除受体肿瘤细胞和残留的免疫细胞。随后,建立了几种临床模型来确定具有移植物抗白血病 (GVL) 作用而不发生移植物抗宿主病 (GVHD) 的最佳供体。此外,还提出了关于特定有益的受体-配体对和 KIR 基因的假说,并正在研究同种反应性 NK 细胞的有利作用。此外,随着对 HSCT 后 NK 细胞重建过程的深入了解,观察到了该过程中涉及的新因素和先前模型的缺陷。在这篇综述中,我们总结了关于 NK 细胞同种反应性对移植结果的影响以及影响 NK 细胞重建的因素的最相关文献。

相似文献

1
Influence of KIR and NK Cell Reconstitution in the Outcomes of Hematopoietic Stem Cell Transplantation.KIR 和 NK 细胞重建对造血干细胞移植结局的影响。
Front Immunol. 2020 Sep 2;11:2022. doi: 10.3389/fimmu.2020.02022. eCollection 2020.
2
The impact of donor and recipient KIR genes and KIR ligands on the occurrence of acute graft-versus-host disease and graft survival after HLA-identical sibling hematopoietic stem cell transplantation.供者和受者 KIR 基因和 KIR 配体对 HLA 相合同胞造血干细胞移植后急性移植物抗宿主病的发生和移植物存活的影响。
Turk J Med Sci. 2018 Aug 16;48(4):794-804. doi: 10.3906/sag-1712-75.
3
Donor and host coexpressing KIR ligands promote NK education after allogeneic hematopoietic stem cell transplantation.供者和受者共表达 KIR 配体可促进异基因造血干细胞移植后 NK 细胞的教育。
Blood Adv. 2019 Dec 23;3(24):4312-4325. doi: 10.1182/bloodadvances.2019000242.
4
Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation.HLA匹配的造血细胞移植后NK细胞受体库的重建。
Blood. 2003 May 1;101(9):3730-40. doi: 10.1182/blood-2002-08-2568. Epub 2003 Jan 2.
5
Impact of donor KIRs and recipient KIR/HLA class I combinations on GVHD in patients with acute leukemia after HLA-matched sibling HSCT.HLA 配型同胞造血干细胞移植后供者 KIR 与受者 KIR/HLA Ⅰ类分子组合对急性白血病患者移植物抗宿主病的影响。
Hum Immunol. 2020 Jun;81(6):285-292. doi: 10.1016/j.humimm.2020.03.004. Epub 2020 Mar 18.
6
Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.KIR基因型的供受者匹配可减少慢性移植物抗宿主病,且缺乏抑制性KIR配体可预防清髓性、HLA匹配的造血细胞移植后的复发。
PLoS One. 2016 Jun 24;11(6):e0158242. doi: 10.1371/journal.pone.0158242. eCollection 2016.
7
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality.KIR 配体错配供者的单倍体造血移植伴有激活型 KIR 可降低非复发死亡率。
Blood. 2015 May 14;125(20):3173-82. doi: 10.1182/blood-2014-09-599993. Epub 2015 Mar 13.
8
Impact of KIR/HLA Incompatibilities on NK Cell Reconstitution and Clinical Outcome after T Cell-Replete Haploidentical Hematopoietic Stem Cell Transplantation with Posttransplant Cyclophosphamide.KIR/HLA 不相容对 T 细胞耗竭的单倍体造血干细胞移植后环磷酰胺治疗后 NK 细胞重建和临床结果的影响。
J Immunol. 2019 Apr 1;202(7):2141-2152. doi: 10.4049/jimmunol.1801489. Epub 2019 Feb 20.
9
Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation.Killer Ig-like receptor 介导的自然杀伤细胞同种异体反应性在单倍体造血干细胞移植中的控制作用。
Blood. 2011 Jan 20;117(3):764-71. doi: 10.1182/blood-2010-08-264085. Epub 2010 Oct 1.
10
NK cells expressing inhibitory KIR for non-self-ligands remain tolerant in HLA-matched sibling stem cell transplantation.表达抑制性杀伤细胞免疫球蛋白样受体(KIR)以识别非自身配体的 NK 细胞在 HLA 匹配的同胞干细胞移植中保持耐受。
Blood. 2010 Apr 1;115(13):2686-94. doi: 10.1182/blood-2009-07-229740. Epub 2010 Jan 22.

引用本文的文献

1
Natural Killer (NK) Cell Alloreactivity in Haploidentical Stem Cell Transplantation.单倍体相合干细胞移植中的自然杀伤(NK)细胞同种异体反应性
Cells. 2025 Jul 16;14(14):1091. doi: 10.3390/cells14141091.
2
High KIR diversity in Uganda and Botswana children living with HIV.乌干达和博茨瓦纳感染艾滋病毒儿童的杀伤细胞免疫球蛋白样受体多样性高。
bioRxiv. 2024 Dec 7:2024.12.03.626612. doi: 10.1101/2024.12.03.626612.
3
Prognostic significance of early nk cell recovery in pediatric t-cell replete allogeneic hematopoietic stem cell transplantation.

本文引用的文献

1
Investigation of donor KIR content and matching in children undergoing hematopoietic cell transplantation for acute leukemia.急性白血病造血细胞移植患儿供体杀伤细胞免疫球蛋白样受体(KIR)含量及匹配情况的研究
Blood Adv. 2020 Apr 14;4(7):1350-1356. doi: 10.1182/bloodadvances.2019001284.
2
Presence of donor-encoded centromeric KIR B content increases the risk of infectious mortality in recipients of myeloablative, T-cell deplete, HLA-matched HCT to treat AML.供体编码的着丝粒KIR B含量的存在增加了接受清髓性、T细胞去除、HLA匹配的造血干细胞移植治疗急性髓细胞白血病患者的感染性死亡风险。
Bone Marrow Transplant. 2020 Oct;55(10):1975-1984. doi: 10.1038/s41409-020-0858-9. Epub 2020 Mar 13.
3
儿童T细胞充足的异基因造血干细胞移植中早期NK细胞恢复的预后意义
Ann Hematol. 2024 Dec;103(12):5769-5780. doi: 10.1007/s00277-024-06084-1. Epub 2024 Nov 16.
4
Natural killer cell engagers: From bi-specific to tri-specific and tetra-specific engagers for enhanced cancer immunotherapy.自然杀伤细胞衔接器:从双特异性到三特异性和四特异性衔接器,用于增强癌症免疫治疗。
Clin Transl Med. 2024 Nov;14(11):e70046. doi: 10.1002/ctm2.70046.
5
Therapeutic Inducers of Natural Killer cell Killing (ThINKK): preclinical assessment of safety and efficacy in allogeneic hematopoietic stem cell transplant settings.自然杀伤细胞杀伤的治疗诱导剂(THiNK):同种异体造血干细胞移植环境中的安全性和疗效的临床前评估。
J Immunother Cancer. 2024 May 15;12(5):e008435. doi: 10.1136/jitc-2023-008435.
6
Advancements in HLA Typing Techniques and Their Impact on Transplantation Medicine.HLA分型技术的进展及其对移植医学的影响。
Med Princ Pract. 2024;33(3):215-231. doi: 10.1159/000538176. Epub 2024 Mar 5.
7
Determination for KIR genotype and allele copy number via real-time quantitative PCR method.通过实时定量 PCR 方法测定 KIR 基因型和等位基因拷贝数。
Immunogenetics. 2024 Apr;76(2):137-143. doi: 10.1007/s00251-023-01331-7. Epub 2024 Jan 11.
8
Systematic evaluation of donor-KIR/recipient-HLA interactions in HLA-matched hematopoietic cell transplantation for AML.AML 患者接受 HLA 匹配造血细胞移植中供者 KIR/受者 HLA 相互作用的系统评价
Blood Adv. 2024 Feb 13;8(3):581-590. doi: 10.1182/bloodadvances.2023011622.
9
Significance of HLA-E and its two NKG2 receptors in development of complications after allogeneic transplantation of hematopoietic stem cells.HLA-E 及其两个 NKG2 受体在异基因造血干细胞移植后并发症发展中的意义。
Front Immunol. 2023 Oct 13;14:1227897. doi: 10.3389/fimmu.2023.1227897. eCollection 2023.
10
Beyond αβ T cells: NK, iNKT, and γδT cell biology in leukemic patients and potential for off-the-shelf adoptive cell therapies for AML.超越 αβ T 细胞:白血病患者中的 NK、iNKT 和 γδT 细胞生物学,以及 AML 现货过继细胞疗法的潜力。
Front Immunol. 2023 Aug 15;14:1202950. doi: 10.3389/fimmu.2023.1202950. eCollection 2023.
KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation.
KIR B 供者可改善接受低强度预处理和无关供者移植的 AML 患者的结局。
Blood Adv. 2020 Feb 25;4(4):740-754. doi: 10.1182/bloodadvances.2019001053.
4
Donor and host coexpressing KIR ligands promote NK education after allogeneic hematopoietic stem cell transplantation.供者和受者共表达 KIR 配体可促进异基因造血干细胞移植后 NK 细胞的教育。
Blood Adv. 2019 Dec 23;3(24):4312-4325. doi: 10.1182/bloodadvances.2019000242.
5
Epstein-Barr virus infections are strongly dependent on activating and inhibitory KIR-HLA pairs after T-cell replate unrelated hematopoietic stem cell transplantation, the principles, and method of pairing analysis.在 T 细胞再植无关造血干细胞移植后, Epstein-Barr 病毒感染强烈依赖于激活和抑制性 KIR-HLA 对,配对分析的原理和方法。
HLA. 2019 Dec;94 Suppl 2:40-48. doi: 10.1111/tan.13770.
6
Distinct Effects of Immunosuppressive Drugs on the Anti- Activity of Human Natural Killer Cells.免疫抑制药物对人自然杀伤细胞抗活性的不同影响。
Pathogens. 2019 Nov 19;8(4):246. doi: 10.3390/pathogens8040246.
7
Increased Relapse Risk of Acute Lymphoid Leukemia in Homozygous HLA-C1 Patients after HLA-Matched Allogeneic Transplantation: A Japanese National Registry Study.HLA 匹配同种异体移植后纯合 HLA-C1 患者急性淋巴细胞白血病复发风险增加:日本全国登记研究。
Biol Blood Marrow Transplant. 2020 Mar;26(3):431-437. doi: 10.1016/j.bbmt.2019.10.032. Epub 2019 Nov 6.
8
Killer Immunoglobulin-Like Receptor-Ligand Interactions Predict Clinical Outcomes following Unrelated Donor Transplantations.杀伤细胞免疫球蛋白样受体-配体相互作用可预测无关供体移植后的临床结局。
Biol Blood Marrow Transplant. 2020 Apr;26(4):672-682. doi: 10.1016/j.bbmt.2019.10.016. Epub 2019 Oct 30.
9
Influence of donor KIR genotypes on reduced relapse risk in acute myelogenous leukemia after hematopoietic stem cell transplantation in patients with CMV reactivation.供者 KIR 基因型对巨细胞病毒激活后造血干细胞移植治疗的急性髓细胞白血病患者复发风险降低的影响。
Leuk Res. 2019 Dec;87:106230. doi: 10.1016/j.leukres.2019.106230. Epub 2019 Sep 28.
10
Haploidentical transplantation in high-risk pediatric leukemia: A retrospective comparative analysis on behalf of the Spanish working Group for bone marrow transplantation in children (GETMON) and the Spanish Grupo for hematopoietic transplantation (GETH).高危型儿科白血病的单倍体移植:西班牙儿童骨髓移植工作组(GETMON)和西班牙造血移植组(GETH)的回顾性对比分析。
Am J Hematol. 2020 Jan;95(1):28-37. doi: 10.1002/ajh.25661. Epub 2019 Nov 5.